Skip to content
MarketScale
‹ Back to IndustriesHealthcare

How One Doctor Uses 3D Printing for Custom Surgical Guides

Custom surgical guides help improve placement and surgical success. Dr. Kristian Buedts, MD, a foot and ankle surgeon at ZNA Middleheim in Antwerp, Belgium recently shared how he uses weight bearing CT scans to create his own surgical guides, and then how he 3D prints those guides at his hospital. Dr. Buedts highlighted the challenges…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
How One Doctor Uses 3D Printing for Custom Surgical Guides

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Custom surgical guides help improve placement and surgical success. Dr. Kristian Buedts, MD, a foot and ankle surgeon at ZNA Middleheim in Antwerp, Belgium recently shared how he uses weight bearing CT scans to create his own surgical guides, and then how he 3D prints those guides at his hospital.

Dr. Buedts highlighted the challenges associated with arthrosis in younger patients, noting that osteo-arthritis typically develops in younger patients as a post-traumatic symptom. More than half the time, the condition presents as asymmetrical wear of the tibio-talar joint (Witteveen 2013), and realignment surgery is often considered to avoid the implications of ankle replacement and joint fusion in younger patients (Krahenbauhl 2017).

These surgeries have been made easier by the accurate 3D representations made possible with weight bearing CT scans, providing professionals like Dr. Buedts with a more consistent pre-operative planning process that included the following steps:

  • Computer simulation software aids in generation of 3D models
  • Displacement is calculated by comparing the affected bone to the normal side through superimposition
  • Virtual osteotomies are conducted
  • Commercial software helps translate these simulations into custom-made guides
  • These guides are 3D printed to assist with the actual surgery

In one case, a patient with ankle instability in the ankle joint as a result of ligamentous laxity and a complex cavo-varus deformity with congruent varus deformity in the ankle joint, among other problems, underwent a corrective dome osteotomy.

While cases such as the patient’s are often hard to reproduce and are difficult to operate on, Dr. Buedts and his team utilized weight bearing CT imaging and the 3D printing of pre-operative guides that were used during the procedure to achieve an extremely positive outcome.

To learn more about the possibilities of weight bearing CT imaging, visit curvebeam.com/contact/.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended AstraZeneca and Daiichi Sankyo’s Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly is investing $6.5 billion in a Houston manufacturing facility set to open around 2030, primarily to scale production of Foundayo, its oral GLP-1 treatment. The project signals a broader shift in U.S. pharmaceutical manufacturing reshoring and underscores the supply chain challenge of forecasting demand and building capacity years in advance for breakthrough therapeutics.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain: Lilly's CEO noted that one-third of new GLP-1 pill patients are now choosing Foundayo, illustrating fast-moving market share shifts that complicate production planning years in advance
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

Waiting for perfectly clean data is stalling healthcare AI, not protecting it

Healthcare organizations often delay AI initiatives waiting for perfectly clean data, but this assumption no longer holds: reliable subsets and synthetic data allow projects to start now while data work continues in parallel. Success requires starting with business outcomes rather than technology capabilities, and embedding governance in product strategy before implementation, not after.

  • 01Waiting for 100% clean data is effectively a decision never to start; hospital AI projects can begin on reliable data subsets while quality work continues in parallel.
  • 02Frame AI decisions around business outcomes (revenue growth, cost reduction, competitive advantage, new products, or ecosystem influence) rather than asking what AI can do.
  • 03Governance should be part of product strategy before design or purchase, especially as agentic AI takes actions—such as handling many revenue-cycle denials—while routing the rest to humans.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512